Loading chat...
NY A02534
Bill
Status
1/17/2025
Primary Sponsor
John McDonald
Click for details
AI Summary
-
Licensed pharmacists may initiate treatment for COVID-19, influenza, and strep throat (Group A streptococcal infection) following a positive test result, under a statewide protocol developed by the Department of Health
-
Pharmacists must ask patients if they have a primary care provider and maintain an updated list of local primary care providers to give patients who lack one
-
The Department of Health must maintain a searchable online list of primary care providers by zip code, including federally qualified health centers, providers serving Medicaid and low-income patients, and information on cultural and linguistic capabilities
-
Pharmacists must retain records of test results and treatment, and report this information to the patient's designated physician, physician assistant, or nurse practitioner unless the patient directs otherwise
-
The law takes effect immediately and automatically expires on April 1, 2028
Legislative Description
Provides for the initiation of treatment for COVID-19, influenza, and pharyngitis resulting from a Group A streptococcal infection by a licensed pharmacist in certain circumstances.
Last Action
referred to higher education
1/7/2026